Wednesday, July 8, 2026

biotech · Bile acid diarrhoea · Transthyretin cardiac amyloidosis · GLUE

Monte Rosa Therapeutics

News and analysis for Monte Rosa Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Boston, USA HQ
213 Employees
Public company Type
GLUE · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Employees
213
Programs
7
Drugs
14
Patents
72
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Monte Rosa Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Monte Rosa Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Monte Rosa Therapeutics yet.

Back to company overview →